The Healthcare ETF Showdown: Broad Global Health or Targeted Pharma Power?
· fool.com · popularity 20/100 · 0 similar stories today
Read the original at fool.com →
Summary
PJP delivered 32.8% returns over one year with concentrated U.S. pharma exposure, while IXJ offers broader global healthcare diversification and a …
Found in: The Motley Fool. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 3.